Goralatide Ac SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) is a naturally occurring tetrapeptide derived from endogenous metabolic processes in the human body, generated from thymosin β4 through enzymatic hydrolysis. As a structurally simple small signal peptide, it is widely distributed across various tissues and body fluids and participates in multi-level physiological regulatory networks. Ac-SDKP tends to work as a "systemic regulator," preserving microenvironmental stability through a mild, ongoing process, in contrast to single-function-directed molecules. Additionally, it usually occurs at low concentrations in vivo but has long-lasting regulatory effects in complex systems, illustrating the high regulatory efficiency of tiny molecules. For this reason, this type of endogenous peptide is increasingly regarded as an important signaling bridge connecting different physiological processes. Its molecular characteristics indicate that it does not rely on strong single-receptor activation but instead embeds itself in physiological systems through multi-pathway, low-intensity regulatory actions, thereby playing a coordinating role in complex cell-matrix signaling networks.
How does Ac-SDKP participate in biological regulation?
Anti-fibrotic Effects
Angiogenesis is a critical process for tissue repair and regeneration. By stimulating endothelial cell proliferation and migration, Ac-SDKP promotes capillary formation, thereby supporting vascular reconstruction. Angiogenesis not only restores blood supply to damaged areas but also improves nutrient and oxygen delivery to tissues. In conditions such as cardiovascular disease, diabetic retinopathy, and other disorders resulting from vascular injury, promoting angiogenesis is vital for tissue repair. Ac-SDKP enhances endothelial cell angiogenic capacity, facilitating the formation of new capillaries and driving the restoration of blood circulation, thereby accelerating the healing of damaged tissues. Particularly in cerebrocardiovascular diseases-such as coronary heart disease and stroke-Ac-SDKP's promotion of angiogenesis not only improves local blood supply but also creates favorable conditions for subsequent therapeutic interventions.
Anti-inflammatory Effects
Ac-SDKP exhibits significant anti-inflammatory activity, effectively inhibiting inflammatory responses and reducing the production of inflammatory mediators. Macrophages are key immune cells involved in inflammatory processes; their infiltration into lesional tissues is closely linked to the release of pro-inflammatory factors. By attenuating macrophage infiltration and suppressing the expression of pro-inflammatory cytokines-such as TNF-α-Ac-SDKP significantly ameliorates inflammatory responses. Furthermore, Ac-SDKP mitigates immune responses triggered by cellular stress by inhibiting NF-κB activation induced by endoplasmic reticulum stress. The NF-κB pathway is a critical intracellular regulatory mechanism for inflammatory responses; excessive activation of this pathway can lead to persistent tissue damage. By modulating this pathway, Ac-SDKP effectively reduces tissue injury, demonstrating significant therapeutic potential-particularly in the context of chronic inflammatory conditions such as cardiovascular, pulmonary, and renal diseases.
Promoting Angiogenesis
Angiogenesis is a critical process for tissue repair and regeneration. By stimulating endothelial cell proliferation and migration, Ac-SDKP promotes capillary formation, thereby supporting vascular reconstruction. Angiogenesis enhances nutrient and oxygen delivery to tissues and restores blood flow to injured areas. Promoting angiogenesis is essential for tissue healing in diseases such as diabetic retinopathy, cardiovascular disease, and other conditions caused by vascular injury. Ac-SDKP increases endothelial cell angiogenic potential, promoting the development of new capillaries and restoring blood flow, thereby accelerating the healing of injured tissues. Particularly in cerebrocardiovascular diseases-such as coronary heart disease and stroke-Ac-SDKP's promotion of angiogenesis not only improves local blood supply but also creates favorable conditions for subsequent therapeutic interventions.
Stem Cell Regulatory Function
As an inhibitor of primitive hematopoietic stem cells, Ac-SDKP plays a crucial role in regulating stem cells. It functions by maintaining stem cells in the G0/G1 phase, thereby preventing their excessive proliferation and subsequent damage. The body's self-repair and regeneration processes depend heavily on stem cells; this is especially important after chemotherapy or radiation therapy, when stem cells are more vulnerable to harm, which can subsequently impair the body's ability to heal. By regulating the stem cell cycle, Ac-SDKP maintains stem cell stability and viability, thereby mitigating damage inflicted by external stressors (such as radiotherapy and chemotherapy). This mechanism holds significant potential for broad application in both stem cell therapy and cancer treatment. In particular, Ac-SDKP supports the long-term survival and functional integrity of stem cells in the setting of hematopoietic stem cell transplantation and post-chemotherapy/radiation cancer care. Through this regulatory action, Ac-SDKP opens up new therapeutic avenues for cellular repair and regeneration, while simultaneously enhancing the efficacy of stem cell-based therapies.
Biological Roles
From a holistic system perspective, Ac-SDKP acts more like a stabilizing regulator. It coordinates cell renewal, structural homeostasis, and signal regulation, enabling tissues to maintain stable operation amidst continuous change. Simultaneously, it enhances the microenvironment's adaptability to change, allowing the system to adjust more smoothly to internal and external fluctuations, rather than reacting drastically. Furthermore, this effect does not rely on a single pathway but is gradually manifested through multi-level synergy, resulting in gentler, more continuous overall regulation. In complex environments, this characteristic helps reduce the risk of system imbalance and improves long-term stability. With the cumulative effect of environmental changes, this "buffered regulation" also makes it easier for tissues to maintain relatively ideal functional ranges.
Biological Profile
As an endogenous peptide derived from in vivo metabolism, Ac-SDKP is well tolerated in physiological systems. Its mechanism of action is primarily low-intensity, gradual regulation, favoring long-term homeostasis over short-term, drastic intervention. In multi-signaling networks, it typically plays a "harmonizing role," coordinating different pathways to maintain a stable overall system rhythm. Furthermore, due to its natural origin, its presence in the system aligns more closely with the physiological environment's operating logic, reducing the likelihood of disrupting existing equilibrium. During sustained action, this mild nature helps reduce the additional burden on the system, making the regulatory process more controllable. Simultaneously, this low-intervention characteristic makes it a more suitable reference molecule for understanding complex physiological regulatory mechanisms.